8-KShareholder Matters

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Shareholder Vote Results (Sep 26, 2014)

Filed September 26, 2014For Securities:ALNY

Summary

This Form 8-K filing from Alnylam Pharmaceuticals, Inc. reports the results of its 2014 Annual Meeting of Stockholders held on September 25, 2014. The primary purpose of the filing is to inform investors about the outcomes of various shareholder votes. Key decisions included the re-election of three Class I directors, the approval of executive compensation in an advisory vote, and the ratification of PricewaterhouseCoopers LLP as the company's independent auditor for the fiscal year 2014. Overall, the results indicate strong shareholder support for the company's leadership and governance. The re-election of directors passed with significant 'For' votes, and the advisory vote on executive compensation also received majority approval. The ratification of the independent auditor was overwhelmingly supported. This filing provides transparency on important corporate governance matters and reassures investors about the company's operational and oversight structures.

Key Highlights

  • 1Alnylam Pharmaceuticals held its 2014 Annual Meeting of Stockholders on September 25, 2014.
  • 2Three Class I directors (John M. Maraganore, Ph.D., Paul R. Schimmel, Ph.D., and Phillip A. Sharp, Ph.D.) were re-elected by stockholders.
  • 3The re-elected directors will serve until the Company's 2017 annual meeting of stockholders.
  • 4Stockholders approved, in a non-binding advisory vote, the compensation of the Company's named executive officers.
  • 5PricewaterhouseCoopers LLP was ratified as the Company's independent auditors for the fiscal year ending December 31, 2014.
  • 6The company had 76,365,403 shares issued and outstanding as of the record date (August 15, 2014).

Frequently Asked Questions

The main outcomes were the re-election of three Class I directors, the approval (in an advisory vote) of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2014.

The filing pertains to the election of Class I directors, not executive officers directly. Three Class I directors were re-elected by the stockholders, and their terms will continue until the 2017 annual meeting. The compensation of named executive officers was approved in an advisory vote.

PricewaterhouseCoopers LLP was ratified by the stockholders as the company's independent auditors for the fiscal year ending December 31, 2014.

A non-binding advisory vote, often referred to as 'Say-on-Pay', allows stockholders to express their opinion on the company's executive compensation policies and decisions. While the vote's outcome is not legally binding, it provides valuable feedback to the Board of Directors regarding shareholder sentiment on compensation matters.